AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10450383
Drug: Balanced salt
RxNorm normalized name: Balanced Salt Solution
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Balanced salt solution intracamerally (control group)
Trial: 6101459
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg synthetic beta-endorphin
Trial: 21175373
Drug: Oxybutynin IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin IR 15 mg/day
Trial: 19411362
Drug: Clinical vignettes
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical vignettes manipulating expected progress and patient adherence to treatment
Trial: 17713338
Drug: Sugar-free gum
RxNorm normalized name: Diabetic Multivitamin Sugar-Free Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugar-free gum containing 20 mg citric acid and 18.8 mg CPP-ACP
Trial: 17713338
Drug: Sugar-free gum
RxNorm normalized name: Diabetic Multivitamin Sugar-Free Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugar-free gum containing 20 mg citric acid alone
Trial: 11254818
Drug: Oral corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral corticosteroids (median prednisolone dose 61 g)
Trial: 3278494
Drug: Butorphanol, mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butorphanol, mean dose 4.8 ± 0.4 mg
Trial: 3278494
Drug: Diazepam, mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam, mean dose 12.0 ± 1.0 mg
Trial: 28707325
Drug: Remifentanil 1
RxNorm normalized name: remifentanil 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 1 μg/kg just before the scalp incision
Trial: 23144449
Drug: Increased HCQ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased HCQ dose to achieve target [HCQ] ≥1000 ng/ml (group 2)
Trial: 23144449
Drug: No daily
RxNorm normalized name: Aveeno Daily Moisturizing
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No daily dose change (group 1)
Trial: 9178335
Drug: Nortriptyline (50-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nortriptyline (50-150 ng/ml)
Trial: 27075687
Drug: Standard continuous
RxNorm normalized name: Uniphyllin Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard continuous positive airway pressure (CPAP) therapy
Trial: 14567091
Drug: Margarine with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Margarine with plant sterol esters (30 g/d with 8 g/100 g of product)
Trial: 14567091
Drug: Butter (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butter (30 g/d)
Trial: 1390962
Drug: Immediate treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate treatment group (psychological treatment package including relaxation training, electromyogram, and thermal biofeedback)
Trial: 16494632
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (delayed treatment)
Trial: 3883902
Drug: Topical minoxidil
RxNorm normalized name: MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Stafenit Hair Regrowth Treatment Topical Minoxidil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical minoxidil therapy (1.0 mL applied twice a day)
Trial: 3883902
Drug: Topical minoxidil
RxNorm normalized name: MINOXIDIL 50 mg in 1 mL TOPICAL SOLUTION [Stafenit Hair Regrowth Treatment Topical Minoxidil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical minoxidil therapy
Trial: 31474546
Drug: Romiplostim 10
RxNorm normalized name: Romiplostim
DrugBank: Romiplostim (DB05332)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Romiplostim 10 μg/kg once weekly
Trial: 31474546
Drug: Romiplostim 6
RxNorm normalized name: Romiplostim
DrugBank: Romiplostim (DB05332)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Romiplostim 6 μg/kg once weekly
Trial: 31474546
Drug: Romiplostim 3
RxNorm normalized name: Romiplostim
DrugBank: Romiplostim (DB05332)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Romiplostim 3 μg/kg once weekly
Trial: 31474546
Drug: Romiplostim 1
RxNorm normalized name: ROMIPLOSTIM 125MCG/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Romiplostim 1 μg/kg once weekly
Trial: 31474546
Drug: Death during
RxNorm normalized name: Immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Death during treatment
Trial: 22441892
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg daily for 6 months
Trial: 22441892
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg daily for 6 months
Trial: 23106243
Drug: 400 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 μg misoprostol
Trial: 23106243
Drug: 800 μg
RxNorm normalized name: hyaluronidase
DrugBank: Hyaluronidase (DB14740)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 800 μg misoprostol
Trial: 11728269
Drug: Calcium Heparin
RxNorm normalized name: HEPARIN CALCIUM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium Heparin (CH) - 12,500 IU subcutaneous daily for 3 months, followed by 325 mg ASA daily for 3 months
Trial: 11728269
Drug: Acetylsalicylic Acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic Acid (ASA) - 325 mg/day for 6 months
Trial: 23835185
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with pseudo-intervention of one oral education session
Trial: 17875340
Drug: Epoetin beta
RxNorm normalized name: Epoetin beta
DrugBank: Epoetin beta (DB19434)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Epoetin beta 150 IU/kg three times weekly until 4 weeks after last chemotherapy cycle
Trial: 15986591
Drug: CMF as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMF as preoperative second-line chemotherapy
Trial: 15986591
Drug: Paclitaxel or
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel or docetaxel as second-line treatment
Trial: 12454562
Drug: Rivastigmine (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivastigmine (9 mg/day)
Trial: 10554542
Drug: Selenium treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium treatment for 19 days in addition to a complete in-patient rehabilitation cure based on a behavioural approach
Trial: 8974615
Drug: Short-acting GnRH
RxNorm normalized name: Short-acting sulfonamides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-acting GnRH agonist (effective for 24 hours)
Trial: 1718252
Drug: Laser treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser treatment for classic CNV
Trial: 1718252
Drug: Laser treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser treatment for subfoveal recurrent CNV
Trial: 6352267
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg oral)
Trial: 8095507
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg three times daily)
Trial: 9926571
Drug: Alcohol (100
RxNorm normalized name: Polyvinyl Alcohol (100000 Mw)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (100 mg/100 ml dose)
Trial: 2838221
Drug: Uniroid ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uniroid ointment
Trial: 2838221
Drug: Proctosedyl ointment
DrugBank: Esculin (DB13155)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proctosedyl ointment
Trial: 2838221
Drug: Uniroid suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uniroid suppository
Trial: 2838221
Drug: Proctosedyl suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proctosedyl suppository
Trial: 2838221
Drug: Both ointment
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both ointment and suppository formulations
Trial: 2838221
Drug: All four
RxNorm normalized name: Jackson's The Original All Fours
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All four preparations
Trial: 31995570
Drug: Daily lipid‐based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily lipid‐based micronutrient supplement commencing ≥3 months prior to conception (Arm 1)
Trial: 31995570
Drug: Daily lipid‐based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily lipid‐based micronutrient supplement in the 1st trimester (Arm 2)
Trial: 31995570
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no supplement, Arm 3)
Trial: 29446523
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy with dapagliflozin 10 mg/d plus saxagliptin 5 mg/d plus metformin
Trial: 29446523
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy with dapagliflozin or saxagliptin plus metformin
Trial: 29446523
Drug: Sequential add-on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential add-on therapy with dapagliflozin 10 mg/d or saxagliptin 5 mg/d
Trial: 29446523
Drug: Concomitant add-on
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant add-on therapy with dapagliflozin 10 mg/d plus saxagliptin 5 mg/d
Trial: 28449699
Drug: Full-length shoe-stiffening
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-length shoe-stiffening insert(s) plus rehabilitation therapy
Trial: 28449699
Drug: Sham shoe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham shoe insert(s) plus rehabilitation therapy
Trial: 26134993
Drug: Heparin and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin and protamine dosing with Hepcon HMS Plus device
Trial: 26134993
Drug: Standard weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard weight and activated clotting time (ACT) based dosing
Trial: 22834636
Drug: 15(R/S)-methyl-lipoxin A(4)
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 15(R/S)-methyl-lipoxin A(4) cream
Trial: 21054484
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of 0.5 mL of hypertonic saline
Trial: 21054484
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of 0.5 mL of isotonic saline
Trial: 18298709
Drug: Intravenous lorazepam
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lorazepam 1 mg
Trial: 16376489
Drug: Cisplatin 100
RxNorm normalized name: CISPLATIN 100MG/VIL (PF) INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin 100 mg/m2 (D1, D22, D43); 5FU, continuous infusion (D1‐‐>D5), 750 mg/m2/day cycle 1; 430 mg/m2/day cycles 2 and 3
Trial: 16376489
Drug: Cisplatin/5-FU chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin/5-FU chemotherapy (arm B)
Trial: 12821730
Drug: Insulin (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin (1.0 mU x kg(‐1) x min(‐1)) plus dextrose to maintain euglycemia
Trial: 10587317
Drug: Danish vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danish vaccine (normal dose, 0.05 ml) given to neonates at birth
Trial: 10587317
Drug: Danish vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danish vaccine (half the normal dose) given at birth
Trial: 10587317
Drug: IRP vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IRP vaccine given at birth at normal infant dose
Trial: 10587317
Drug: Danish vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danish vaccine (normal infant dose) given at 3 months of age
Trial: 8561341
Drug: 0.9% sodium
RxNorm normalized name: LMD with 0.9% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% sodium chloride solution (Control)
Trial: 1670113
Drug: L-PAM (melphalan)
RxNorm normalized name: L-PAM
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-PAM (melphalan) or L-PAM plus fluorouracil
Trial: 6120059
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg CZP nightly with no antacid
Trial: 6120059
Drug: CZP nightly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CZP nightly for 30 ml Maalox
Trial: 6120059
Drug: CZP nightly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CZP nightly with Maalox with an additional 30 ml Maalox three times daily
Trial: 6120059
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antacid)
Trial: 30224529
Drug: Chinfloxacin 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinfloxacin 400 mg
Trial: 30224529
Drug: Chinfloxacin 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinfloxacin 600 mg
Trial: 30224529
Drug: Chinfloxacin (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinfloxacin (single and multiple doses)
Trial: 21862748
Drug: Anti-IL-12/23 therapies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-IL-12/23 therapies (ustekinumab and briakinumab)
Trial: 21862748
Drug: Anti-TNF-α agents
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-TNF-α agents (adalimumab, etanercept, infliximab)
Trial: 21862748
Drug: Placebo (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (for anti-IL-12/23 therapies)
Trial: 21862748
Drug: Placebo (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (for anti-TNF-α agents)
Trial: 19065858
Drug: Repetition condition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repetition condition (same emotional face image presented twice)
Trial: 14651700
Drug: Listening to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Listening to music for 20 minutes daily
Trial: 14651700
Drug: Sitting quietly
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sitting quietly for 20 minutes daily (Control)
Trial: 10981543
Drug: Combination diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination diet rich in fruits, vegetables, low-fat dairy, whole grains, fish, poultry, and nuts; reduced in fats, red meats, sweets, and sugar-containing beverages for 8 weeks
Trial: 9601228
Drug: Myofunctional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myofunctional therapy and orthodontic appliances (e.g., activators)
Trial: 24875194
Drug: Losartan 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 0.1 mg/kg per day
Trial: 24875194
Drug: Losartan 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 0.3 mg/kg per day
Trial: 24875194
Drug: Losartan 0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 0.7 mg/kg per day
Trial: 24875194
Drug: Losartan (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (up to 1.4 mg/kg per day)
Trial: 21810842
Drug: Aspirin taken
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin taken in the evening for 1 month
Trial: 21810842
Drug: Aspirin taken
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin taken in the morning for 1 month
Trial: 21810842
Drug: Aspirin taken
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin taken in the evening
Trial: 21810842
Drug: Aspirin taken
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin taken in the morning
Trial: 19952833
Drug: Yoga therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga therapy (YG)
Trial: 15892268
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (TCM) intervention
Trial: 10720532
Drug: OspA vaccine
RxNorm normalized name: OspA protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OspA vaccine recipients
Trial: 10720532
Drug: OspA vaccine
RxNorm normalized name: OspA protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OspA vaccine recipients with Lyme disease
Trial: 7559202
Drug: Rufloxacin 400
RxNorm normalized name: ofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rufloxacin 400 mg
Trial: 30223226
Drug: Fulvestrant plus
RxNorm normalized name: Fulvestrant
DrugBank: Fulvestrant (DB00947)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Fulvestrant plus goserelin (F + G)
Trial: 30223226
Drug: Anastrozole plus
RxNorm normalized name: Anastrozole
DrugBank: Anastrozole (DB01217)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anastrozole plus goserelin (A + G)
Trial: 30223226
Drug: Goserelin (G)
DrugBank: Goserelin (DB00014)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Goserelin (G) alone
Trial: 16221299
Drug: Problem Solving
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem Solving Treatment (PST) provided by nurses
Trial: 12099989
Drug: Neoral oral
RxNorm normalized name: Neoral Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoral oral solution diluted in apple juice
Trial: 12099989
Drug: Neoral oral
RxNorm normalized name: Neoral Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoral oral solution diluted in tap water
Trial: 8071496
Drug: Moderate diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate diet (1.3 g protein/kg/day, 16-20 mg phosphorus/kg/day)
Trial: 8071496
Drug: Low diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low diet (0.575 g protein/kg/day, 5-10 mg phosphorus/kg/day)
Trial: 8071496
Drug: Very low
RxNorm normalized name: Very low fat spread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very low diet with keto or amino acids (0.28 g protein/kg/day, 4-9 mg phosphorus/kg/day)
Trial: 3378276
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of gentamicin and methicillin
Trial: 3378276
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of gentamicin and cloxacillin
Trial: 3378276
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of clindamycin and mezlocillin
Trial: 31113531
Drug: Surgeon's preference
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgeon's preference (e.g. fistulotomy, cutting seton, advancement flap, LIFT procedure)
Trial: 10704632
Drug: Simvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (10 mg)
Trial: 27276165
Drug: Naproxen (250mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (250mg TID for 10 days) and physical therapy
Trial: 15898434
Drug: Erythromycin stinoprate
RxNorm normalized name: erythromycin stinoprate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin stinoprate capsules 250 mg
Trial: 15898434
Drug: Erythromycin stinoprate
RxNorm normalized name: erythromycin stinoprate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin stinoprate capsules 500 mg
Trial: 15898434
Drug: Erythromycin stinoprate
RxNorm normalized name: erythromycin stinoprate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin stinoprate capsules 750 mg
Trial: 12480357
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (250 mg prednisolone reduced by 25 mg per day, 500 mL 6% hydroxyethyl starch, 400 mg pentoxifylline per day)
Trial: 9659643
Drug: rHuEPO (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHuEPO (300 U/kg per dose, twice a week)
Trial: 7858363
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (2 mg in 3 ml saline) administered before the onset of pain (Group B)
Trial: 7858363
Drug: Epidural saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural saline (3 ml) administered before the onset of pain (Group A)
Trial: 7858363
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (2 mg in 3 ml saline) administered after the onset of pain (Group B)
Trial: 2576663
Drug: Somatostatin infusion
RxNorm normalized name: somatostatin
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin infusion (250 micrograms/h in 100 ml saline)